© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
Meropenem and vaborbactam is indicated for the treatment of complicated urinary tract infections for patients aged 18 years and older.
Medication Pearl of the Day: Meropenem and vaborbactam (Vabomere)
Indication: Meropenem and vaborbactam (Vabomere) is a combination of meropenem, which is a penem antibacterial, and vaborbactam, a beta-lactamase inhibitor. Meropenem and vaborbactam is indicated for the treatment of patients aged 18 years and older with complicated urinary tract infections (cUTI), such as pyelonephritis caused by designated susceptible bacteria.